Retrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments
NCT ID: NCT06997549
Last Updated: 2025-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
12000 participants
OBSERVATIONAL
2025-05-15
2035-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
NCT03065335
McLean and Genomind Prospective Study
NCT03113890
Nebulized Ketamine for the Treatment of Major Depressive Disorder in an Inpatient Setting
NCT06752759
This is a Study to Determine the Antidepressant Effects of AZD6765
NCT00986479
Brain Network Dynamics of Depression During Esketamine Treatment
NCT06012916
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Patients treated with NeuroStar TMS
non-invasive brain stimulation device
Patients treated with Esketamine
nasal spray for treating depression
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age reported and not an invalid entry
* Treatment date in 2011 or later.
Exclusion Criteria
5 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Neuronetics
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eleanor Cole, PhD
Role: STUDY_DIRECTOR
Neuronetics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Neuronetics
Malvern, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Eleanor Cole
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11-10002-000
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.